Meghan Fitzgerald

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA.

Pfizer Global Pharmaceuticals, Inc. manufactures, and markets prescription medicines. It markets medicines for diseases which include infections, arthritis, depression, hypertension and other heart disorders, as well as certain types of cancer. Pfizer Global Pharmaceuticals is located in New York, NY.

Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA.

Cardinal Health 122 LLC provides online comprehensive, customized health care management solutions. The company is headquartered in Dallas, TX.

Seniorlink, Inc. provides eldercare advice and care management services at home for aging parents and relatives. The company delivers structured family care giving service for individuals who need significant help with activities of daily living. The company was founded by E. Byron Hensley Jr. in 2000 and is headquartered in Boston, MA.

Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom.

LetterOne Holdings SA (L1) is an independent private equity firm headquartered in Luxembourg, Luxembourg. The firm was founded in 2013 by Mikhail Fridman.

Letterone Investment Holdings SARL (Letterone) is a private equity firm founded in 2013. The firm is headquartered in Luxembourg.

Destination Pet LLC engages in the provision of animal care services. It offers styling, training, and home care services. The company was founded by Thomas Wille, Kimberly Young, Mike Williams and Danielle Palmer in 2017 and is headquartered in Highlands Ranch, CO.

K2 HealthVentures Group LLC (K2 HealthVentures) is a venture capital firm founded in 2018 by Meghan FitzGerald. The firm is headquartered in Boston, Miami with an additional office in New York.

Thimble Point Acquisition Corp. operates as a blank check company. Its purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on December 1, 2020 and is headquartered in New Haven, CT.

Thimble Point Acquisition Corp. II is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 9, 2021 and is headquartered in New Haven, CT.